Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing 5 ACT Regimens for Uncomplicated Falciparum Malaria
NCT00902811Phase 4Unknown
- Sponsor
- Médecins Sans Frontières
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate, mefloquine, artemether, lumefantrine, dihydroartemisinin in Malaria, sponsored by Médecins Sans Frontières. Status: unknown.
02
Drugs
artesunatemefloquineartemetherlumefantrinedihydroartemisinin
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00902811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902811.